Hurria A - Search Results

1

Patterns of toxicity in older patients with breast cancer receiving adjuvant chemotherapy.

Hurria A, Brogan K, Panageas KS, Pearce C, Norton L, Jakubowski A, Zauderer M, Howard J, Hudis C. Hurria A, et al. Breast Cancer Res Treat. 2005 Jul;92(2):151-6. doi: 10.1007/s10549-005-1410-8. Breast Cancer Res Treat. 2005. PMID: 15986124

2

Factors influencing treatment patterns of breast cancer patients age 75 and older.

Hurria A, Leung D, Trainor K, Borgen P, Norton L, Hudis C. Hurria A, et al. Crit Rev Oncol Hematol. 2003 May;46(2):121-6. doi: 10.1016/s1040-8428(02)00133-6. Crit Rev Oncol Hematol. 2003. PMID: 12711357 Review.

3

Follow-up care of breast cancer survivors.

Hurria A, Hudis C. Hurria A, et al. Crit Rev Oncol Hematol. 2003 Oct;48(1):89-99. doi: 10.1016/s1040-8428(03)00097-0. Crit Rev Oncol Hematol. 2003. PMID: 14585486 Review.

4

Screening chest imaging studies are not effective in the follow-up of breast cancer patients.

Hurria A, Leung D, Trainor K, Norton L, Hudis C. Hurria A, et al. J Oncol Manag. 2003 Sep-Oct;12(5):13-5. J Oncol Manag. 2003. PMID: 14619990

5

Management of lung cancer in older adults.

Hurria A, Kris MG. Hurria A, et al. CA Cancer J Clin. 2003 Nov-Dec;53(6):325-41. doi: 10.3322/canjclin.53.6.325. CA Cancer J Clin. 2003. PMID: 15224973 Free article. Review.

6

Phase II study of feasibility of dose-dense FEC followed by alternating weekly taxanes in high-risk, four or more node-positive breast cancer.

Dang CT, D'Andrea GM, Moynahan ME, Dickler MN, Seidman AD, Fornier M, Robson ME, Theodoulou M, Lake D, Currie VE, Hurria A, Panageas KS, Norton L, Hudis CA. Dang CT, et al. Among authors: hurria a. Clin Cancer Res. 2004 Sep 1;10(17):5754-61. doi: 10.1158/1078-0432.CCR-04-0634. Clin Cancer Res. 2004. PMID: 15355903 Clinical Trial.

7

Change in cycle 1 to cycle 2 haematological counts predicts toxicity in older patients with breast cancer receiving adjuvant chemotherapy.

Hurria A, Brogan K, Panageas KS, Jakubowski A, Zauderer M, Pearce C, Norton L, Howard J, Hudis C. Hurria A, et al. Drugs Aging. 2005;22(8):709-15. doi: 10.2165/00002512-200522080-00007. Drugs Aging. 2005. PMID: 16060720

8

Effect of creatinine clearance on patterns of toxicity in older patients receiving adjuvant chemotherapy for breast cancer.

Hurria A, Hurria A, Brogan K, Panageas KS, Pearce C, Norton L, Jakubowski A, Howard J, Hudis C. Hurria A, et al. Drugs Aging. 2005;22(9):785-91. doi: 10.2165/00002512-200522090-00007. Drugs Aging. 2005. PMID: 16156682

9

Developing a cancer-specific geriatric assessment: a feasibility study.

Hurria A, Gupta S, Zauderer M, Zuckerman EL, Cohen HJ, Muss H, Rodin M, Panageas KS, Holland JC, Saltz L, Kris MG, Noy A, Gomez J, Jakubowski A, Hudis C, Kornblith AB. Hurria A, et al. Cancer. 2005 Nov 1;104(9):1998-2005. doi: 10.1002/cncr.21422. Cancer. 2005. PMID: 16206252 Free article.

10

Effect of adjuvant breast cancer chemotherapy on cognitive function from the older patient's perspective.

Hurria A, Goldfarb S, Rosen C, Holland J, Zuckerman E, Lachs MS, Witmer M, van Gorp WG, Fornier M, D'Andrea G, Moasser M, Dang C, Van Poznak C, Robson M, Currie VE, Theodoulou M, Norton L, Hudis C. Hurria A, et al. Breast Cancer Res Treat. 2006 Aug;98(3):343-8. doi: 10.1007/s10549-006-9171-6. Epub 2006 Mar 16. Breast Cancer Res Treat. 2006. PMID: 16541322

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

283 results

Search Page